Day & Ennis’s CVS Health CVS Stock Holding History

Day & Ennis’s Portfolio CVS Stock Details CVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,301	Closed	-$214K	–	124
2022 Q4	$214K	Buy	+2,301	New	+$222K	0.08%	109
2016 Q2	–	Sell	-1,950	Closed	-$202K	–	72
2016 Q1	$202K	Buy	+1,950	New	+$190K	0.22%	64

Other funds holding CVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Day & Ennis's CVS Position: Q1 2023 in Review

Day & Ennis sold out of CVS Health (CVS) in Q1 2023, closing a stake of 2,301 shares — an estimated $214K sold.

Day & Ennis first reported a position in CVS in Q1 2016 and held it in 2 quarters. The position peaked at $214K in Q4 2022. 2,267 funds tracked by Wall St. Rank hold CVS as of Q1 2023.

Day & Ennis reported no remaining CVS Health position as of Q1 2023 after selling out during the quarter.
Day & Ennis sold 2,301 CVS Health shares in Q1 2023, an estimated $214K.
Day & Ennis first reported a position in CVS Health in Q1 2016 and held it in 2 quarters.
Day & Ennis's CVS Health position peaked at $214K in Q4 2022.
2,267 funds tracked by Wall St. Rank held CVS Health as of Q1 2023.

Based on Day & Ennis's 13F filing for Q1 2023, filed 24 Apr 2023.